11 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Microwave Ablation Generator (KY-2000A, KY-2100A)

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

Guerbet

FDA UDI
Shenzhen Boon Medical Supply Co., Ltd.·06938327906931·24h CT 200/200ml Syringes(Orange)

EUROIMMUN IFA 40: HEP-20-10; EUROPATTERN MICROSCOPE AND SOFTWARE

FDA 510(k)
FDA Class 2 ·Immunology

DUALFLEX RX ERCP CANNULA, MODELS 4681, 4682

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

MENTOR SILTEX ROUND MODERATE PROFILE

FDA Adverse Event
Injury ·MENTOR TEXAS·Product code FWM·May 14, 2019

FLOGARD

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - SINGAPORE·Product code FRN·September 9, 2011

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code OYC·November 10, 2014

MECHANICAL WALKER, ROLLATOR

FDA Adverse Event
KENSTONE METAL·Product code ITJ·July 22, 2013

ARCOS 17X150MM SPL TPR DIST

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWA·June 12, 2024

ARCOS CON SZ C STD 60MM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWA·June 12, 2024

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014